Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Flu Sends Scientists Dipping for Gold

Published: Wednesday, December 11, 2013
Last Updated: Wednesday, December 11, 2013
Bookmark and Share
Researchers on the Norwich Research Park have patented a quick, simple dipstick flu test using sugar labelled with gold.

Quick diagnosis of flu is important because vaccination and antiviral drugs need to be administered to patients within 48 hours of infection to prevent new pandemics arising.

“We are now looking for a diagnostics company to help us bring it to market,” said Professor Rob Field from the John Innes Centre.

He and Professor David Russell from the University of East Anglia found that a gold solution changes colour in the presence of the flu virus. And the colour it changes to differs according to the strain of flu.

Results published in Organic & Biomolecular Chemistry show that gold nanoparticles can be used to detect the human influenza virus X31 (H3N2) within 30 minutes and to distinguish between human and avian influenza.

Prof Field explains that 90% of human infections use carbohydrate recognition to bind with targets in the body. The sensor is a suspension of sugars tagged with gold particles. If the flu virus is present, it will attach to a sugar, pulling particles closer together. Human and avian flu have a preference for different sugar chains resulting in a colour change visible to the naked eye.

“The same basic principles can be applied wherever rapid detection is required from detecting superbugs in hospitals to biohazards such as ricin,” said Professor Field.

The researchers have already developed a carbohydrate-based sensor to detect cholera in contaminated water supplies.

“Our technique based on gold nanoparticles is much faster than current methods of detection,” said Professor Russell from UEA.

Professor Russell leads a spinout company, Intelligent Fingerprinting, based on drug and drug metabolite screening using the sweat contained in fingerprints. Government funding is being used to develop a patented handheld device for use in Accident and Emergency and coroner services.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
Developing Drug Resistance may be a Matter of Diversity for Tuberculosis
Researchers have probed the bacteria that causes tuberculosis, Mycobacterium tuberculosis, to learn more about how individual bacterial cells change and adapt while in the human body.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
Essential Component of Antiviral Defense Identified
Infectious disease researchers at the University of Georgia have identified a signaling protein critical for host defense against influenza infection.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Is Allergy the Price We Pay for Our Immunity to Parasites?
New findings help demonstrate the evolutionary basis for allergy.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
Mucus – the First Line of Defence
Researchers reveal the important role of mucus in building a good defence against invaders.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos